Artwork

Content provided by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Leverage Your Impact

53:10
 
Share
 

Manage episode 433817815 series 2352501
Content provided by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Welcome to the latest episode of Try Not 2 Blink. In today's discussion, hosts Roya and Sheila will share recently published research in retinal ophthalmology. They will review the good, bad, and ugly and how it relates to clinical care. Among the topics covered will be the potential benefits of melatonin in reducing the risk of developing and progressing age-related macular degeneration (AMD), as well as why aspirin is not recommended for patients with AMD.
Then they welcome Dr. George Magrath to the show, a distinguished ocular oncology ophthalmologist and CEO of Ocuphire. Dr. Magrath will review the steps to increase his leverage on healthcare by obtaining "game-changing" higher education; he will give his pearls on looking for retinal changes and what the future holds for treating diabetic retinopathy.
Tune in next week for another engaging and lighthearted episode with Roya and Sheila on Try Not 2 Blink.
We value your input! If you have suggestions for topics or potential guests you would like to see featured on Try Not 2 Blink, please email us at trynot2blinkshow@gmail.com or click here to share your ideas.
SOURCES

Dr. George Magrath: LinkedIn

Dr. George Magrath: MUSC

Dr. Magrath appointed CEO/Director of Ocuphire

Interview with Dr. Magrath

Zeta 1 + APX3330

Good, Bad, Ugly

Ozempic and eye health

Melanoma Tips

Aura Pharma

Try Not to Blink Podcast is powered by Valley Contax

  continue reading

300 episodes

Artwork

Leverage Your Impact

Try Not To Blink

21 subscribers

published

iconShare
 
Manage episode 433817815 series 2352501
Content provided by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Roya Habibi OD & Sheila Morrison OD, Roya Habibi OD, and Sheila Morrison OD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Welcome to the latest episode of Try Not 2 Blink. In today's discussion, hosts Roya and Sheila will share recently published research in retinal ophthalmology. They will review the good, bad, and ugly and how it relates to clinical care. Among the topics covered will be the potential benefits of melatonin in reducing the risk of developing and progressing age-related macular degeneration (AMD), as well as why aspirin is not recommended for patients with AMD.
Then they welcome Dr. George Magrath to the show, a distinguished ocular oncology ophthalmologist and CEO of Ocuphire. Dr. Magrath will review the steps to increase his leverage on healthcare by obtaining "game-changing" higher education; he will give his pearls on looking for retinal changes and what the future holds for treating diabetic retinopathy.
Tune in next week for another engaging and lighthearted episode with Roya and Sheila on Try Not 2 Blink.
We value your input! If you have suggestions for topics or potential guests you would like to see featured on Try Not 2 Blink, please email us at trynot2blinkshow@gmail.com or click here to share your ideas.
SOURCES

Dr. George Magrath: LinkedIn

Dr. George Magrath: MUSC

Dr. Magrath appointed CEO/Director of Ocuphire

Interview with Dr. Magrath

Zeta 1 + APX3330

Good, Bad, Ugly

Ozempic and eye health

Melanoma Tips

Aura Pharma

Try Not to Blink Podcast is powered by Valley Contax

  continue reading

300 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide